ATI RN ADULT MEDICAL SURGICAL TEST PAPER
2026 COMPLETE RESPONSES GRADED A+
◉ serum phosphorus. Answer: 2.5-4.5 mg/dL
◉ hypophosphatemia risk factors. Answer: vitamin D deficiency
refeeding after starvation
alochol use disorder
DKA
alkalosis
hypomagnesemia
hypokalemia
excessive loss of body fluids: sweat, diarrhea, vomiting,
hyperventilation
burns
TPN
overdose of antacids
◉ hypophosphatemia manifestations. Answer: parethesia, muscle
weakness
*bone pain and deformities*
chest pain
,confusion
seizures
nystagmus
◉ hypophosphatemia interventions. Answer: oral phosphate
replacement
careful IV admin of phosphorus
gradual introduction of solution for clients on TPN
protection from isolation
seizure precautions
◉ hyperphosphatemia risk factors. Answer: renal failure -
*glomerulonephritis*
chemotherapy
acute pancreatitis
high vitamin D
hypoparathyroidim
excessive enema use
acidosis
◉ hyperphosphatemia manifestations. Answer: tetany, cramps
paresthesia
,dysrhythmias
Tousseau's sign
Chvostek's sign
hyperreflexia
anorexia, N/V
soft tissue calcifications
◉ hyperphosphatemia interventions. Answer: meds: *vitamin D,
aluminum hydroxide, diuretics*
IV NS
dialysis
dietary management and education
◉ Serum Magnesium. Answer: 1.5-2.5 mEq/L
◉ hypomagnesemia risk factors. Answer: GI loss
alcoholism
hypocalcemia, hypokalemia
DKA
hyperparathyroidism
malabsorption
TPN
, laxative abuse
acute MI
meds: cysplatin, cyclosporine, aminoglycosides, diuretics,
amphoteracin B
◉ hypomagnesemia manifestations. Answer: paresthesia
dysrhythmias
Trousseau's sign
Chvostek's sign
agitation, confusion
hyperreflexia
HTN
insomnia, irritability
anorexia, N/V
dysphagia
prolonged QT interval
◉ hypomagnesemia interventions. Answer: seizure precautions
monitor swallowing
dietary measures and education
administer meds: IV mag sulfate, PO mag salts
--*should not be administer to clients in renal failure*
2026 COMPLETE RESPONSES GRADED A+
◉ serum phosphorus. Answer: 2.5-4.5 mg/dL
◉ hypophosphatemia risk factors. Answer: vitamin D deficiency
refeeding after starvation
alochol use disorder
DKA
alkalosis
hypomagnesemia
hypokalemia
excessive loss of body fluids: sweat, diarrhea, vomiting,
hyperventilation
burns
TPN
overdose of antacids
◉ hypophosphatemia manifestations. Answer: parethesia, muscle
weakness
*bone pain and deformities*
chest pain
,confusion
seizures
nystagmus
◉ hypophosphatemia interventions. Answer: oral phosphate
replacement
careful IV admin of phosphorus
gradual introduction of solution for clients on TPN
protection from isolation
seizure precautions
◉ hyperphosphatemia risk factors. Answer: renal failure -
*glomerulonephritis*
chemotherapy
acute pancreatitis
high vitamin D
hypoparathyroidim
excessive enema use
acidosis
◉ hyperphosphatemia manifestations. Answer: tetany, cramps
paresthesia
,dysrhythmias
Tousseau's sign
Chvostek's sign
hyperreflexia
anorexia, N/V
soft tissue calcifications
◉ hyperphosphatemia interventions. Answer: meds: *vitamin D,
aluminum hydroxide, diuretics*
IV NS
dialysis
dietary management and education
◉ Serum Magnesium. Answer: 1.5-2.5 mEq/L
◉ hypomagnesemia risk factors. Answer: GI loss
alcoholism
hypocalcemia, hypokalemia
DKA
hyperparathyroidism
malabsorption
TPN
, laxative abuse
acute MI
meds: cysplatin, cyclosporine, aminoglycosides, diuretics,
amphoteracin B
◉ hypomagnesemia manifestations. Answer: paresthesia
dysrhythmias
Trousseau's sign
Chvostek's sign
agitation, confusion
hyperreflexia
HTN
insomnia, irritability
anorexia, N/V
dysphagia
prolonged QT interval
◉ hypomagnesemia interventions. Answer: seizure precautions
monitor swallowing
dietary measures and education
administer meds: IV mag sulfate, PO mag salts
--*should not be administer to clients in renal failure*
